-
1
-
-
0004027213
-
-
5th Ed. Hamilton ON: BC Decker
-
Bast R Jr, Kufe DW, Pollock RE, Weichselbaum RR, Holland JF, Frei E III, Gansler TS. Cancer Medicine. 5th ed. Hamilton, ON: BC Decker; 2000.
-
(2000)
Cancer Medicine
-
-
Bast Jr., R.1
Kufe, D.W.2
Pollock, R.E.3
Weichselbaum, R.R.4
Holland, J.F.5
Frei III, E.6
Gansler, T.S.7
-
2
-
-
0027397762
-
Desmoplasia and its relevance to colorectal tumour invasion
-
DOI 10.1002/ijc.2910530113
-
Hewitt RE, Powe DG, Carter GI, Turner DR. Desmoplasia and its relevance to colorectal tumour invasion. Int J Cancer. 1993;53(1):62-69. (Pubitemid 23018424)
-
(1993)
International Journal of Cancer
, vol.53
, Issue.1
, pp. 62-69
-
-
Hewitt, R.E.1
Powe, D.G.2
Carter, G.I.3
Turner, D.R.4
-
3
-
-
0030051051
-
Cellular changes involved in conversion of normal to malignant breast: Importance of the stromal reaction
-
Rønnov-Jessen L, Petersen OW, Bissell MJ. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev. 1996;76(1):69-125. (Pubitemid 26048279)
-
(1996)
Physiological Reviews
, vol.76
, Issue.1
, pp. 69-125
-
-
Ronnov-Jessen, L.1
Petersen, O.W.2
Bissell, M.J.3
-
4
-
-
8144228952
-
Friends or foes - Bipolar effects of the tumour stroma in cancer
-
DOI 10.1038/nrc1477
-
Mueller MM, Fusenig NE. Friends or foes\-bipolar effects of the tumour stroma in cancer. Nat Rev Cancer. 2004;4(11):839-849. (Pubitemid 39472951)
-
(2004)
Nature Reviews Cancer
, vol.4
, Issue.11
, pp. 839-849
-
-
Mueller, M.M.1
Fusenig, N.E.2
-
5
-
-
3142512612
-
Molecular characterization of the tumor microenvironment in breast cancer
-
DOI 10.1016/j.ccr.2004.06.010, PII S1535610804001783
-
Allinen M, Beroukhim R, Cai L, et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell. 2004;6(1):17-32. (Pubitemid 38903159)
-
(2004)
Cancer Cell
, vol.6
, Issue.1
, pp. 17-32
-
-
Allinen, M.1
Beroukhim, R.2
Cai, L.3
Brennan, C.4
Lahti-Domenici, J.5
Huang, H.6
Porter, D.7
Hu, M.8
Chin, L.9
Richardson, A.10
Schnitt, S.11
Sellers, W.R.12
Polyak, K.13
-
6
-
-
75849154010
-
Cancer associated fibro-blasts in cancer pathogenesis
-
Franco OE, Shaw AK, Strand DW, Hayward SW. Cancer associated fibro-blasts in cancer pathogenesis. Semin Cell Dev Biol. 2010;21(1):33-39.
-
(2010)
Semin Cell Dev Biol
, vol.21
, Issue.1
, pp. 33-39
-
-
Franco, O.E.1
Shaw, A.K.2
Strand, D.W.3
Hayward, S.W.4
-
7
-
-
75849159205
-
Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression
-
Shimoda M, Mellody KT, Orimo A. Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression. Semin Cell Dev Biol. 2010;21(1):19-25.
-
(2010)
Semin Cell Dev Biol
, vol.21
, Issue.1
, pp. 19-25
-
-
Shimoda, M.1
Mellody, K.T.2
Orimo, A.3
-
8
-
-
60949101225
-
Cancer-associated fibroblasts and tumor growth- bystanders turning into key players
-
Ostman A, Augsten M. Cancer-associated fibroblasts and tumor growth- bystanders turning into key players. Curr Opin Genet Dev. 2009;19(1):67-73.
-
(2009)
Curr Opin Genet Dev
, vol.19
, Issue.1
, pp. 67-73
-
-
Ostman, A.1
Augsten, M.2
-
9
-
-
33745837774
-
Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake
-
DOI 10.1172/JCI26532
-
Loeffler M, Krüger JA, Niethammer AG, Reisfeld RA. Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. J Clin Invest. 2006;116(7):1955-1962. (Pubitemid 44033319)
-
(2006)
Journal of Clinical Investigation
, vol.116
, Issue.7
, pp. 1955-1962
-
-
Loeffler, M.1
Kruger, J.A.2
Niethammer, A.G.3
Reisfeld, R.A.4
-
10
-
-
78149298209
-
Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha
-
Kraman M, Bambrough PJ, Arnold JN, et al. Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha. Science. 2010;330(6005):827-830.
-
(2010)
Science
, vol.330
, Issue.6005
, pp. 827-830
-
-
Kraman, M.1
Bambrough, P.J.2
Arnold, J.N.3
-
11
-
-
84856934228
-
Rationale behind targeting fibro-blast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy
-
Brennen WN, Isaacs JT, Denmeade SR. Rationale behind targeting fibro-blast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy. Mol Cancer Ther. 2012;11(2):257-266.
-
(2012)
Mol Cancer Ther
, vol.11
, Issue.2
, pp. 257-266
-
-
Brennen, W.N.1
Isaacs, J.T.2
Denmeade, S.R.3
-
12
-
-
0025083528
-
Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers
-
Garin-Chesa P, Old LJ, Rettig WJ. Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proc Natl Acad Sci USA. 1990;87(18):7235-7239.
-
(1990)
Proc Natl Acad Sci USA
, vol.87
, Issue.18
, pp. 7235-7239
-
-
Garin-Chesa, P.1
Old, L.J.2
Rettig, W.J.3
-
13
-
-
53149100519
-
Seprase: An overview of an important matrix serine protease
-
O'Brien P, O'Connor BF. Seprase: an overview of an important matrix serine protease. Biochim Biophys Acta. 2008;1784(9):1130-1145.
-
(2008)
Biochim Biophys Acta
, vol.1784
, Issue.9
, pp. 1130-1145
-
-
O'Brien, P.1
O'Connor, B.F.2
-
14
-
-
76349097770
-
The dipeptidyl peptidase IV family in cancer and cell biology
-
Yu DM, Yao TW, Chowdhury S, et al. The dipeptidyl peptidase IV family in cancer and cell biology. FEBS J. 2010;277(5):1126-1144.
-
(2010)
FEBS J
, vol.277
, Issue.5
, pp. 1126-1144
-
-
Yu, D.M.1
Yao, T.W.2
Chowdhury, S.3
-
15
-
-
33344475312
-
1-cleaving specificity
-
DOI 10.1016/j.febslet.2006.01.087, PII S0014579306001578
-
Edosada CY, Quan C, Tran T, et al. Peptide substrate profiling defines fibroblast activation protein as an endopeptidase of strict Gly(2)-Pro(1)- cleaving specificity. FEBS Lett. 2006;580(6):1581-1586. (Pubitemid 43290354)
-
(2006)
FEBS Letters
, vol.580
, Issue.6
, pp. 1581-1586
-
-
Edosada, C.Y.1
Quan, C.2
Tran, T.3
Pham, V.4
Wiesmann, C.5
Fairbrother, W.6
Wolf, B.B.7
-
16
-
-
0033579444
-
Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts
-
Park JE, Lenter MC, Zimmermann RN, Garin-Chesa P, Old LJ, Rettig WJ. Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J Biol Chem. 1999;274(51):36505-36512.
-
(1999)
J Biol Chem
, vol.274
, Issue.51
, pp. 36505-36512
-
-
Park, J.E.1
Lenter, M.C.2
Zimmermann, R.N.3
Garin-Chesa, P.4
Old, L.J.5
Rettig, W.J.6
-
17
-
-
38349169216
-
Fibroblast activation protein peptide substrates identified from human collagen i derived gelatin cleavage sites
-
Aggarwal S, Brennen WN, Kole T P, et al. Fibroblast activation protein peptide substrates identified from human collagen I derived gelatin cleavage sites. Biochemistry. 2008;47(3):1076-1086.
-
(2008)
Biochemistry
, vol.47
, Issue.3
, pp. 1076-1086
-
-
Aggarwal, S.1
Brennen, W.N.2
Kole, T.P.3
-
18
-
-
33846018363
-
2- antiplasmin cleaving enzyme on collagen Types I, III, and IV
-
DOI 10.1016/j.abb.2006.11.006, PII S0003986106004371
-
Christiansen VJ, Jackson KW, Lee KN, McKee PA. Effect of fibroblast activation protein and alpha2-antiplasmin cleaving enzyme on collagen types I, III, and I V. Arch Biochem Biophys. 2007;457(2):177-186. (Pubitemid 46048698)
-
(2007)
Archives of Biochemistry and Biophysics
, vol.457
, Issue.2
, pp. 177-186
-
-
Christiansen, V.J.1
Jackson, K.W.2
Lee, K.N.3
McKee, P.A.4
-
19
-
-
0036718369
-
Reactive stroma in human prostate cancer: Induction of myofibroblast phenotype and extracellular matrix remodeling
-
Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, Rowley DR. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res. 2002;8(9):2912-2923. (Pubitemid 35025739)
-
(2002)
Clinical Cancer Research
, vol.8
, Issue.9
, pp. 2912-2923
-
-
Tuxhorn, J.A.1
Ayala, G.E.2
Smith, M.J.3
Smith, V.C.4
Dang, T.D.5
Rowley, D.R.6
-
20
-
-
55949135598
-
Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma
-
Cohen SJ, Alpaugh RK, Palazzo I, et al. Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma. Pancreas. 2008;37(2):154-158.
-
(2008)
Pancreas.
, vol.37
, Issue.2
, pp. 154-158
-
-
Cohen, S.J.1
Alpaugh, R.K.2
Palazzo, I.3
-
21
-
-
34250189539
-
Clinical implications of fibroblast activation protein in patients with colon cancer
-
DOI 10.1158/1078-0432.CCR-06-1746
-
Henry LR, Lee HO, Lee JS, et al. Clinical implications of fibro-blast activation protein in patients with colon cancer. Clin Cancer Res. 2007;13(6):1736-1741. (Pubitemid 46952939)
-
(2007)
Clinical Cancer Research
, vol.13
, Issue.6
, pp. 1736-1741
-
-
Henry, L.R.1
Lee, H.-O.2
Lee, J.S.3
Klein-Szanto, A.4
Watts, P.5
Ross, E.A.6
Chen, W.-T.7
Cheng, J.D.8
-
22
-
-
48749103523
-
Fibroblast activation protein alpha identifies mesenchymal stromal cells from human bone marrow
-
Bae S, Park CW, Son HK, et al. Fibroblast activation protein alpha identifies mesenchymal stromal cells from human bone marrow. Br J Haematol. 2008;142(5):827-830.
-
(2008)
Br J Haematol
, vol.142
, Issue.5
, pp. 827-830
-
-
Bae, S.1
Park, C.W.2
Son, H.K.3
-
23
-
-
0028286026
-
Molecular cloning of fibroblast activation protein α, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers
-
DOI 10.1073/pnas.91.12.5657
-
Scanlan MJ, Raj BK, Calvo B, et al. Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc Natl Acad Sci USA. 1994;91(12):5657-5661. (Pubitemid 24174387)
-
(1994)
Proceedings of the National Academy of Sciences of the United States of America
, vol.91
, Issue.12
, pp. 5657-5661
-
-
Scanlan, M.J.1
Raj, B.K.M.2
Calvo, B.3
Garin-Chesa, P.4
Sanz-Moncasi, M.P.5
Healey, J.H.6
Old, L.J.7
Rettig, W.J.8
-
24
-
-
33244490067
-
Fibroblast activation protein: A serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis
-
DOI 10.1016/j.humpath.2005.11.020, PII S0046817705006908
-
Acharya PS, Zukas A, Chandan V, Katzenstein AL, Puré E. Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis. Hum Pathol. 2006;37(3):352-360. (Pubitemid 43277524)
-
(2006)
Human Pathology
, vol.37
, Issue.3
, pp. 352-360
-
-
Acharya, P.S.1
Zukas, A.2
Chandan, V.3
Katzenstein, A.-L.A.4
Pure, E.5
-
25
-
-
0033034717
-
Fibroblast activation protein: A cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis
-
DOI 10.1002/hep.510290631
-
Levy MT, McCaughan GW, Abbott CA, et al. Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis. Hepatology. 1999;29(6):1768-1778. (Pubitemid 29247051)
-
(1999)
Hepatology
, vol.29
, Issue.6
, pp. 1768-1778
-
-
Levy, M.T.1
McCaughan, G.W.2
Abbott, C.A.3
Park, J.E.4
Cunningham, A.M.5
Muller, E.6
Rettig, W.J.7
Gorrell, M.D.8
-
26
-
-
0027302568
-
Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin
-
Rettig WJ, Garin-Chesa P, Healey JH, et al. Regulation and hetero-meric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin. Cancer Res. 1993;53(14):3327-3335. (Pubitemid 23223305)
-
(1993)
Cancer Research
, vol.53
, Issue.14
, pp. 3327-3335
-
-
Rettig, W.J.1
Garin-Chesa, P.2
Healey, J.H.3
Su, S.L.4
Ozer, H.L.5
Schwab, M.6
Albino, A.P.7
Old, L.J.8
-
27
-
-
70149088171
-
Clonal mutations in the cancer-associated fibroblasts: The case against genetic coevolution
-
discussion 6769
-
Campbell I, Polyak K, Haviv I. Clonal mutations in the cancer-associated fibroblasts: the case against genetic coevolution. Cancer Res. 2009;69(17):6765- 6768; discussion 6769.
-
(2009)
Cancer Res.
, vol.69
, Issue.17
, pp. 6765-6768
-
-
Campbell, I.1
Polyak, K.2
Haviv, I.3
-
28
-
-
69149095336
-
The road to integrative cancer therapies: Emergence of a tumor-associated fibroblast protease as a potential therapeutic target in cancer
-
Puré E. The road to integrative cancer therapies: emergence of a tumor-associated fibroblast protease as a potential therapeutic target in cancer. Expert Opin Ther Targets. 2009;13(8):967-973.
-
(2009)
Expert Opin Ther Targets
, vol.13
, Issue.8
, pp. 967-973
-
-
Puré, E.1
-
29
-
-
33646344722
-
Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity
-
DOI 10.1074/jbc.M511112200
-
Edosada CY, Quan C, Wiesmann C, et al. Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity. J Biol Chem. 2006;281(11):7437-7444. (Pubitemid 43847515)
-
(2006)
Journal of Biological Chemistry
, vol.281
, Issue.11
, pp. 7437-7444
-
-
Edosada, C.Y.1
Quan, C.2
Wiesmann, C.3
Tran, T.4
Sutherlin, D.5
Reynolds, M.6
Elliott, J.M.7
Raab, H.8
Fairbrother, W.9
Wolf, B.B.10
-
30
-
-
0036858613
-
A practical synthesis of l-valyl-pyrrolidine-(2R)-boronic acid: Efficient recycling of the costly chiral auxiliary (+)-pinanediol
-
Gibson F, Singh AK, Soumeillant MC, Manchand PS, Humora M, Kronenthal DR. A practical synthesis of l-valyl-pyrrolidine-(2R)-boronic acid: efficient recycling of the costly chiral auxiliary (+)-pinanediol. Org. Process Res Dev. 2002;6(6):814-816.
-
(2002)
Org. Process Res Dev.
, vol.6
, Issue.6
, pp. 814-816
-
-
Gibson, F.1
Singh, A.K.2
Soumeillant, M.C.3
Manchand, P.S.4
Humora, M.5
Kronenthal, D.R.6
-
31
-
-
0042308774
-
Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer
-
Denmeade SR, Jakobsen CM, Janssen S, et al. Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer. J Natl Cancer Inst. 2003;95(13):990-1000. (Pubitemid 36896716)
-
(2003)
Journal of the National Cancer Institute
, vol.95
, Issue.13
, pp. 990-1000
-
-
Denmeade, S.R.1
Jakobsen, C.M.2
Janssen, S.3
Khan, S.R.4
Garrett, E.S.5
Lilja, H.6
Christensen, S.B.7
Isaacs, J.T.8
-
32
-
-
0033044376
-
2+](i) in individual cells undergoing apoptosis
-
DOI 10.1054/ceca.1998.0005
-
Tombal B, Denmeade SR, Isaacs JT. Assessment and validation of a microinjection method for kinetic analysis of [Ca2+]i in individual cells undergoing apoptosis. Cell Calcium. 1999;25(1):19-28. (Pubitemid 29083988)
-
(1999)
Cell Calcium
, vol.25
, Issue.1
, pp. 19-28
-
-
Tombal, B.1
Denmeade, S.R.2
Isaacs, J.T.3
-
33
-
-
0033151801
-
Inhibition of caspase activity does not prevent the signaling phase of apoptosis in prostate cancer cells
-
DOI 10.1002/(SICI)1097-0045(19990601)39:4<269::AID-PROS7>3.0.CO;2-F
-
Denmeade SR, Lin XS, Tombal B, Isaacs JT. Inhibition of caspase activity does not prevent the signaling phase of apoptosis in prostate cancer cells. Prostate. 1999;39(4):269-279. (Pubitemid 29244501)
-
(1999)
Prostate
, vol.39
, Issue.4
, pp. 269-279
-
-
Denmeade, S.R.1
Lin, X.S.2
Tombal, B.3
Isaacs, J.T.4
-
34
-
-
33749441325
-
Rapid vascular regrowth in tumors after reversal of VEGF inhibition
-
DOI 10.1172/JCI24612
-
Mancuso MR, Davis R, Norberg SM, et al. Rapid vascular regrowth in tumors after reversal of VEGF inhibition. J Clin Invest. 2006;116(10): 2610-2621. (Pubitemid 44511625)
-
(2006)
Journal of Clinical Investigation
, vol.116
, Issue.10
, pp. 2610-2621
-
-
Mancuso, M.R.1
Davis, R.2
Norberg, S.M.3
O'Brien, S.4
Sennino, B.5
Nakahara, T.6
Yao, V.J.7
Inai, T.8
Brooks, P.9
Freimark, B.10
Shalinsky, D.R.11
Hu-Lowe, D.D.12
McDonald, D.M.13
-
35
-
-
77953467629
-
Reversible epithelial to mesenchymal transition and acquired resistance to sunitinib in patients with renal cell carcinoma: Evidence from a xenograft study
-
Hammers HJ, Verheul HM, Salumbides B, et al. Reversible epithelial to mesenchymal transition and acquired resistance to sunitinib in patients with renal cell carcinoma: evidence from a xenograft study. Mol Cancer Ther. 2010;9(6):1525-1535.
-
(2010)
Mol Cancer Ther
, vol.9
, Issue.6
, pp. 1525-1535
-
-
Hammers, H.J.1
Verheul, H.M.2
Salumbides, B.3
-
36
-
-
33644765198
-
Pharmacokinetics, biodistribution, and antitumor efficacy of a human glandular kallikrein 2 (hK2)-activated thapsigargin prodrug
-
DOI 10.1002/pros.20348
-
Janssen S, Rosen DM, Ricklis RM, et al. Pharmacokinetics, biodistribution, and antitumor efficacy of a human glandular kallikrein 2 (hK2)-activated thapsigargin prodrug. Prostate. 2006;66(4):358-368. (Pubitemid 43346946)
-
(2006)
Prostate
, vol.66
, Issue.4
, pp. 358-368
-
-
Janssen, S.1
Rosen, D.M.2
Ricklis, R.M.3
Dionne, C.A.4
Lilja, H.5
Christensen, S.B.6
Isaacs, J.T.7
Denmeade, S.R.8
-
37
-
-
26244432793
-
Proliferating fibroblasts at the invading tumour edge of colorectal adenocarcinomas are associated with endogenous markers of hypoxia, acidity, and oxidative stress
-
DOI 10.1136/jcp.2005.026260
-
Sivridis E, Giatromanolaki A, Koukourakis MI. Proliferating fibroblasts at the invading tumour edge of colorectal adenocarcinomas are associated with endogenous markers of hypoxia, acidity, and oxidative stress. J Clin Pathol. 2005;58(10):1033-1038. (Pubitemid 41416051)
-
(2005)
Journal of Clinical Pathology
, vol.58
, Issue.10
, pp. 1033-1038
-
-
Sivridis, E.1
Giatromanolaki, A.2
Koukourakis, M.I.3
-
38
-
-
0038008281
-
Proliferative activities of tumor stromal cells play important roles in tumor thickness and progression of T3 ulcerative-type colorectal cancer
-
Hasebe T, Sasaki S, Sugitoh M, Ono M, Saitoh N, Ochiai A. Proliferative activities of tumor stromal cells play important roles in tumor thickness and progression of T3 ulcerative-type colorectal cancer. Virchows Arch. 2003;442(6):569-576. (Pubitemid 36819251)
-
(2003)
Virchows Archiv
, vol.442
, Issue.6
, pp. 569-576
-
-
Hasebe, T.1
Sasaki, S.2
Sugitoh, M.3
Ono, M.4
Saitoh, N.5
Ochiai, A.6
-
39
-
-
0027848781
-
Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer
-
Fox SB, Gatter KC, Bicknell R, et al. Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. Cancer Res. 1993;53(18):4161-4163. (Pubitemid 24146759)
-
(1993)
Cancer Research
, vol.53
, Issue.18
, pp. 4161-4163
-
-
Fox, S.B.1
Gatter, K.C.2
Bicknell, R.3
Going, J.J.4
Stanton, P.5
Cooke, T.G.6
Harris, A.L.7
-
40
-
-
0026050850
-
Thapsigargin inhibits the sarcoplasmic or endoplasmic reticulum Ca-ATPase family of calcium pumps
-
Lytton J, Westlin M, Hanley MR. Thapsigargin inhibits the sarcoplasmic or endoplasmic reticulum Ca-ATPase family of calcium pumps. J Biol Chem. 1991;266(26):17067-17071. (Pubitemid 21907906)
-
(1991)
Journal of Biological Chemistry
, vol.266
, Issue.26
, pp. 17067-17071
-
-
Lytton, J.1
Westlin, M.2
Hanley, M.R.3
-
41
-
-
0028143317
-
The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin
-
Furuya Y, Lundmo P, Short AD, Gill DL, Isaacs JT. The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin. Cancer Res. 1994;54(23):6167-6175.
-
(1994)
Cancer Res
, vol.54
, Issue.23
, pp. 6167-6175
-
-
Furuya, Y.1
Lundmo, P.2
Short, A.D.3
Gill, D.L.4
Isaacs, J.T.5
-
42
-
-
24644432531
-
The SERCA pump as a therapeutic target: Making a "smart bomb" for prostate cancer
-
Denmeade SR, Isaacs JT. The SERCA pump as a therapeutic target: making a "smart bomb" for prostate cancer. Cancer Biol Ther. 2005;4(1):14-22. (Pubitemid 41350924)
-
(2005)
Cancer Biology and Therapy
, vol.4
, Issue.1
, pp. 14-22
-
-
Denmeade, S.R.1
Isaacs, J.T.2
-
43
-
-
0030690164
-
Mechanism and role of growth arrest in programmed (apoptotic) death of prostatic cancer cells induced by thapsigargin
-
DOI 10.1002/(SICI)1097-0045(19971101)33:3<201::AID-PROS9>3.0.CO;2-L
-
Lin XS, Denmeade SR, Cisek L, Isaacs JT. Mechanism and role of growth arrest in programmed (apoptotic) death of prostatic cancer cells induced by thapsigargin. Prostate. 1997;33(3):201-207. (Pubitemid 27509421)
-
(1997)
Prostate
, vol.33
, Issue.3
, pp. 201-207
-
-
Lin, X.S.1
Denmeade, S.R.2
Cisek, L.3
Isaacs, J.T.4
-
44
-
-
0025332577
-
Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase
-
Thastrup O, Cullen PJ, Drøbak BK, Hanley MR, Dawson A P. Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase. Proc Natl Acad Sci USA. 1990;87(7):2466-2470.
-
(1990)
Proc Natl Acad Sci USA.
, vol.87
, Issue.7
, pp. 2466-2470
-
-
Thastrup, O.1
Cullen, P.J.2
Drøbak, B.K.3
Hanley, M.R.4
Dawson, A.P.5
-
45
-
-
0025737973
-
2+ transport ATPase by thapsigargin at subnanomolar concentrations
-
Sagara Y, Inesi G. Inhibition of the sarcoplasmic reticulum Ca2+ transport ATPase by thapsigargin at subnanomolar concentrations. J Biol Chem. 1991;266(21):13503-13506. (Pubitemid 21907377)
-
(1991)
Journal of Biological Chemistry
, vol.266
, Issue.21
, pp. 13503-13506
-
-
Sagara, Y.1
Inesi, G.2
-
46
-
-
0028977989
-
Kinetics of thapsigargin-Ca(2+)-ATPase (sarco-plasmic reticulum) interaction reveals a two-step binding mechanism and picomolar inhibition
-
Davidson GA, Varhol RJ. Kinetics of thapsigargin-Ca(2+)-ATPase (sarco-plasmic reticulum) interaction reveals a two-step binding mechanism and picomolar inhibition. J Biol Chem. 1995;270(20):11731-11734.
-
(1995)
J Biol Chem
, vol.270
, Issue.20
, pp. 11731-11734
-
-
Davidson, G.A.1
Varhol, R.J.2
-
47
-
-
0035924210
-
Design, synthesis, and pharmacological evaluation of thapsigargin analogues for targeting apoptosis to prostatic cancer cells
-
DOI 10.1021/jm010985a
-
Jakobsen CM, Denmeade SR, Isaacs JT, Gady A, Olsen CE, Christensen SB. Design, synthesis, and pharmacological evaluation of thapsigargin analogues for targeting apoptosis to prostatic cancer cells. J Med Chem. 2001;44(26):4696- 4703. (Pubitemid 33144479)
-
(2001)
Journal of Medicinal Chemistry
, vol.44
, Issue.26
, pp. 4696-4703
-
-
Jakobsen, C.M.1
Denmeade, S.R.2
Isaacs, J.T.3
Gady, A.4
Olsen, C.E.5
Christensen, S.B.6
-
48
-
-
4143063726
-
Purification, identification and characterisation of seprase from bovine serum
-
DOI 10.1016/j.biocel.2004.05.006, PII S1357272504001992
-
Collins PJ, McMahon G, O'Brien P, O'Connor B. Purification, identification and characterisation of seprase from bovine serum. Int J Biochem Cell Biol. 2004;36(11):2320-2333. (Pubitemid 39094452)
-
(2004)
International Journal of Biochemistry and Cell Biology
, vol.36
, Issue.11
, pp. 2320-2333
-
-
Collins, P.J.1
McMahon, G.2
O'Brien, P.3
O'Connor, B.4
-
49
-
-
2342447229
-
2-antiplasmin inhibition of fibrin digestion
-
DOI 10.1182/blood-2003-12-4240
-
Lee KN, Jackson KW, Christiansen VJ, Chung KH, McKee PA. A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion. Blood. 2004;103(10):3783-3788. (Pubitemid 38596296)
-
(2004)
Blood
, vol.103
, Issue.10
, pp. 3783-3788
-
-
Lee, K.N.1
Jackson, K.W.2
Christiansen, V.J.3
Chung, K.H.4
McKee, P.A.5
-
50
-
-
32644446428
-
Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein
-
DOI 10.1182/blood-2005-08-3452
-
Lee KN, Jackson KW, Christiansen VJ, Lee CS, Chun JG, McKee PA. Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein. Blood. 2006;107(4):1397-1404. (Pubitemid 43242374)
-
(2006)
Blood
, vol.107
, Issue.4
, pp. 1397-1404
-
-
Lee, K.N.1
Jackson, K.W.2
Christiansen, V.J.3
Lee, C.S.4
Chun, J.-G.5
McKee, P.A.6
-
51
-
-
72849125358
-
Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice
-
Santos AM, Jung J, Aziz N, Kissil JL, Puré E. Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice. J Clin Invest. 2009;119(12):3613-3625.
-
(2009)
J Clin Invest
, vol.119
, Issue.12
, pp. 3613-3625
-
-
Santos, A.M.1
Jung, J.2
Aziz, N.3
Kissil, J.L.4
Puré, E.5
-
52
-
-
51649087512
-
Effective immunoconju-gate therapy in cancer models targeting a serine protease of tumor fibro-blasts
-
Ostermann E, Garin-Chesa P, Heider KH, et al. Effective immunoconju-gate therapy in cancer models targeting a serine protease of tumor fibro-blasts. Clin Cancer Res. 2008;14(14):4584-4592.
-
(2008)
Clin Cancer Res
, vol.14
, Issue.14
, pp. 4584-4592
-
-
Ostermann, E.1
Garin-Chesa, P.2
Heider, K.H.3
-
53
-
-
0037989982
-
A phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer
-
Scott AM, Wiseman G, Welt S, et al. A phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin Cancer Res. 2003;9(5):1639-1647. (Pubitemid 36554586)
-
(2003)
Clinical Cancer Research
, vol.9
, Issue.5
, pp. 1639-1647
-
-
Scott, A.M.1
Wiseman, G.2
Welt, S.3
Adjei, A.4
Lee, F.-T.5
Hopkins, W.6
Divgi, C.R.7
Hanson, L.H.8
Mitchell, P.9
Gansen, D.N.10
Larson, S.M.11
Ingle, J.N.12
Hoffman, E.W.13
Tanswell, P.14
Ritter, G.15
Cohen, L.S.16
Bette, P.17
Arvay, L.18
Amelsberg, A.19
Vlock, D.20
Rettig, W.J.21
Old, L.J.22
more..
-
54
-
-
67649666985
-
Phase II trial of talabostat and docetaxel in advanced non-small cell lung cancer
-
Eager RM, Cunningham CC, Senzer N, et al. Phase II trial of talabostat and docetaxel in advanced non-small cell lung cancer. Clin Oncol (R Coll Radiol). 2009;21(6):464-472.
-
(2009)
Clin Oncol (R Coll Radiol).
, vol.21
, Issue.6
, pp. 464-472
-
-
Eager, R.M.1
Cunningham, C.C.2
Senzer, N.3
-
55
-
-
0037219532
-
Stromal antigen targeting by a humanised monoclonal antibody: An early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer
-
DOI 10.1159/000069863
-
Hofheinz RD, al-Batran SE, Hartmann F, et al. Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer. Onkologie. 2003;26(1):44-48. (Pubitemid 36302438)
-
(2003)
Onkologie
, vol.26
, Issue.1
, pp. 44-48
-
-
Hofheinz, R.-D.1
Al-Batran, S.-E.2
Hartmann, F.3
Hartung, G.4
Jager, D.5
Renner, C.6
Tanswell, P.7
Kunz, U.8
Amelsberg, A.9
Kuthan, H.10
Stehle, G.11
-
56
-
-
67349253388
-
Targeted lipid-coated nanoparticles: Delivery of tumor necrosis factor-functionalized particles to tumor cells
-
Messerschmidt SK, Musyanovych A, Altvater M, et al. Targeted lipid-coated nanoparticles: delivery of tumor necrosis factor-functionalized particles to tumor cells. J Control Release. 2009;137(1):69-77.
-
(2009)
J Control Release
, vol.137
, Issue.1
, pp. 69-77
-
-
Messerschmidt, S.K.1
Musyanovych, A.2
Altvater, M.3
-
57
-
-
0041856115
-
Generation of a FasL-based proapoptotic fusion protein devoid of systemic toxicity due to cell-surface antigen-restricted activation
-
DOI 10.1074/jbc.M304866200
-
Samel D, Muller D, Gerspach J, et al. Generation of a FasL-based proa-poptotic fusion protein devoid of systemic toxicity due to cell-surface antigen-restricted Activation. J Biol Chem. 2003;278(34):32077-32082. (Pubitemid 37048396)
-
(2003)
Journal of Biological Chemistry
, vol.278
, Issue.34
, pp. 32077-32082
-
-
Samel, D.1
Muller, D.2
Gerspach, J.3
Assohou-Luty, C.4
Sass, G.5
Tiegs, G.6
Pfizenmaier, K.7
Wajant, H.8
-
58
-
-
38449101374
-
Fibroblast activation protein and chronic liver disease
-
DOI 10.2741/2918
-
Wang XM, Yao TW, Nadvi NA, Osborne B, McCaughan GW, Gorrell MD. Fibroblast activation protein and chronic liver disease. Front Biosci. 2008;13:3168-3180. (Pubitemid 351589228)
-
(2008)
Frontiers in Bioscience
, vol.13
, Issue.8
, pp. 3168-3180
-
-
Xin, M.W.1
Yao, T.-W.2
Nadvi, N.A.3
Osborne, B.4
McCaughan, G.W.5
Gorrell, M.D.6
-
59
-
-
70350542778
-
Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes
-
Bauer S, Jendro MC, Wadle A, et al. Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes. Arthritis Res Ther. 2006;8(6):R171.
-
(2006)
Arthritis Res Ther
, vol.8
, Issue.6
-
-
Bauer, S.1
Jendro, M.C.2
Wadle, A.3
-
60
-
-
70349932641
-
Histogenesis-specific expression of fibroblast activation protein and dipeptidylpeptidase-IV in human bone and soft tissue tumours
-
Dohi O, Ohtani H, Hatori M, et al. Histogenesis-specific expression of fibroblast activation protein and dipeptidylpeptidase-IV in human bone and soft tissue tumours. Histopathology. 2009;55(4):432-440.
-
(2009)
Histopathology
, vol.55
, Issue.4
, pp. 432-440
-
-
Dohi, O.1
Ohtani, H.2
Hatori, M.3
-
61
-
-
65449165652
-
The prolyl-aminodipeptidases and their inhibitors as therapeutic targets for fibrogenic disorders
-
Juillerat-Jeanneret L, Gerber-Lemaire S. The prolyl-aminodipeptidases and their inhibitors as therapeutic targets for fibrogenic disorders. Mini Rev Med Chem. 2009;9(2):215-226.
-
(2009)
Mini Rev Med Chem
, vol.9
, Issue.2
, pp. 215-226
-
-
Juillerat-Jeanneret, L.1
Gerber-Lemaire, S.2
-
62
-
-
0037102412
-
Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model
-
Cheng JD, Dunbrack RL Jr, Valianou M, Rogatko A, Alpaugh RK, Weiner LM. Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model. Cancer Res. 2002;62(16):4767-4772.
-
(2002)
Cancer Res
, vol.62
, Issue.16
, pp. 4767-4772
-
-
Cheng, J.D.1
Dunbrack Jr., R.L.2
Valianou, M.3
Rogatko, A.4
Alpaugh, R.K.5
Weiner, L.M.6
-
63
-
-
70949103794
-
Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model
-
Liao D, Luo Y, Markowitz D, Xiang R, Reisfeld RA. Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model. PLoS ONE. 2009;4(11):e7965.
-
(2009)
PLoS ONE
, vol.4
, Issue.11
-
-
Liao, D.1
Luo, Y.2
Markowitz, D.3
Xiang, R.4
Reisfeld, R.A.5
-
64
-
-
15944389319
-
Seprase Promotes Rapid Tumor Growth and Increased Microvessel Density in a Mouse Model of Human Breast Cancer
-
DOI 10.1158/0008-5472.CAN-03-3184
-
Huang Y, Wang S, Kelly T. Seprase promotes rapid tumor growth and increased microvessel density in a mouse model of human breast cancer. Cancer Res. 2004;64(8):2712-2716. (Pubitemid 38500606)
-
(2004)
Cancer Research
, vol.64
, Issue.8
, pp. 2712-2716
-
-
Huang, Y.1
Wang, S.2
Kelly, T.3
-
65
-
-
3843069939
-
FAPα, a surface peptidase expressed during wound healing, is a tumor suppressor
-
DOI 10.1038/sj.onc.1207730
-
Ramirez-Montagut T, Blachere NE, Sviderskaya EV, et al. FAPalpha, a surface peptidase expressed during wound healing, is a tumor suppressor. Oncogene. 2004;23(32):5435-5446. (Pubitemid 39044054)
-
(2004)
Oncogene
, vol.23
, Issue.32
, pp. 5435-5446
-
-
Ramirez-Montagut, T.1
Blachere, N.E.2
Sviderskaya, E.V.3
Bennett, D.C.4
Rettig, W.J.5
Garin-Chesa, P.6
Houghton, A.N.7
-
66
-
-
0035915797
-
Stromal expression of fibroblast activation protein/seprase, a cell membrane serine proteinase and gelatinase, is associated with longer survival in patients with invasive ductal carcinoma of breast
-
Ariga N, Sato E, Ohuchi N, Nagura H, Ohtani H. Stromal expression of fibroblast activation protein/seprase, a cell membrane serine proteinase and gelatinase, is associated with longer survival in patients with invasive ductal carcinoma of breast. Int J Cancer. 2001;95(1):67-72.
-
(2001)
Int J Cancer
, vol.95
, Issue.1
, pp. 67-72
-
-
Ariga, N.1
Sato, E.2
Ohuchi, N.3
Nagura, H.4
Ohtani, H.5
-
67
-
-
66849140921
-
Amino acid containing thapsigargin analogues deplete androgen receptor protein via synthesis inhibition and induce the death of prostate cancer cells
-
Vander Griend DJ, Antony L, Dalrymple SL, et al. Amino acid containing thapsigargin analogues deplete androgen receptor protein via synthesis inhibition and induce the death of prostate cancer cells. Mol Cancer Ther. 2009;8(5):1340-1349.
-
(2009)
Mol Cancer Ther
, vol.8
, Issue.5
, pp. 1340-1349
-
-
Vander Griend, D.J.1
Antony, L.2
Dalrymple, S.L.3
|